Skip to content

Prospective Study to Evaluate Recovery of Breast Sensory Nerve and Effectiveness of Neurotization Using Acellular Nerve Allograft (SCconnect Flex Nerve) in Breast Reconstruction

Prospective Study to Evaluate Recovery of Breast Sensory Nerve and Effectiveness of Neurotization Using Acellular Nerve Allograft (SCconnect Flex Nerve) in Breast Reconstruction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0010162
Enrollment
30
Registered
2025-01-24
Start date
2025-10-21
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Breast reconstruction surgery will be performed in accordance with the standard surgical method of the operation, and if nerve transplantation using allogeneic nerves is possible d

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women between the ages of 20 and 79. 2. Patients undergoing breast reconstruction using implants following a mastectomy, who understand the purpose of the study and have provided informed consent to participate.

Exclusion criteria

Exclusion criteria: 1. Patients currently taking immunosuppressants or systemic steroids, including oral and injectable formulations (only applicable to those on continuous treatment for at least 4 weeks). 2. Individuals whose mental status, such as alcohol or drug abuse, may interfere with the progress of the clinical study. 3. Individuals who are unable to complete the surveys/questionnaires conducted in this clinical study. 4. Individuals who have participated in another clinical study within 120 days prior to screening (participation is allowed if the investigator determines that the previous study does not affect the current study). 5. Individuals with a history of prior surgery at the breast reconstruction site, such as breast augmentation, tumor excision, or breast-conserving surgery (BCS). 6. Women who are pregnant, breastfeeding, or of childbearing potential during the clinical trial who do not agree to use medically accepted methods of contraception (e.g., sterilization, intrauterine devices (IUDs), oral contraceptives in combination with barrier methods, other hormonal delivery systems with barrier methods, or use of a diaphragm/condom with contraceptive creams, jellies, or foam). 7. Other cases where the investigator deems the subject unsuitable for participation in this clinical study.

Design outcomes

Primary

MeasureTime frame
Assessment of the breast sensory recovery in accordance with the Semmes-Weinstein monofilament test

Secondary

MeasureTime frame
Subject's self-assessment of satisfaction after breast reconstruction by the Breast-Q reconstruction module(survey)

Countries

Korea, Republic of

Contacts

Public ContactJAEHOON JEONG

Seoul National University Bundang Hospital

psdrj2h@gmail.com+82-31-787-7225

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jun 21, 2026